SCOHIA PHARMA is a specialty bioventure with great expertise in the field of lifestyle-related diseases such as cardiovascular, metabolic, and renal diseases.
-
Business
2022.06.27
Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2 Activator
-
Paper
2022.06.17
Publication of medicinal chemistry research on SCO-792, an enteropeptidase inhibitor
-
Business
2021.11.12
Awarded the 3rd prize of the Boehringer Ingelheim Innovation Prize, 2021
Page Top